Anaphylaxis

ASCIA Anaphylaxis e-training for pharmacists 2021-2

Anaphylaxis 2021-2This course provides the most up to date information about prevention, recognition and emergency treatment of anaphylaxis, including information about adrenaline (epinephrine) autoinjectors and ASCIA Action Plans for Anaphylaxis. 

First developed in 2011, the course is reviewed each year or, as needed, by the Australasian Society of Clinical Immunology and Allergy (ASCIA), the peak professional body of allergy and immunology in Australia and New Zealand.

Version 7.0 available from: 14 October 2021 

ASCIA Anaphylaxis e-training for pharmacists 2021

Anaphylaxis

This course provides the most up to date information about  prevention, recognition and emergency treatment of anaphylaxis, including information about adrenaline (epinephrine) autoinjectors and ASCIA Action Plans for Anaphylaxis. 

First developed in 2011, the course is reviewed each year by the Australasian Society of Clinical Immunology and Allergy (ASCIA), the peak professional body of allergy and immunology in Australia and New Zealand.

Version 6.1 available: 6 February 2021 and superseded 14 October 2021 by Version 7.0 available here.

ASCIA Anaphylaxis e-training for pharmacists 2020

Anaphylaxis

This course provides the most up to date information about  prevention, recognition and emergency treatment of anaphylaxis, including information about adrenaline (epinephrine) autoinjectors and ASCIA Action Plans for Anaphylaxis. 

First developed in 2011, the course is reviewed each year by the Australasian Society of Clinical Immunology and Allergy (ASCIA), the peak professional body of allergy and immunology in Australia and New Zealand.